Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Pfizer synthesizes new JAK1 inhibitors

Dec. 17, 2021

Concert Pharmaceuticals presents new JAK inhibitors

Dec. 15, 2021

Ichnos grants Almirall global rights to develop and commercialize ISB-880 for autoimmune diseases

Dec. 14, 2021

New Wnt signaling activators identified at Biosplice Therapeutics

Dec. 9, 2021

BCL10/MALT1 axis found to be involved in psoriasis

Dec. 3, 2021

Targeting TWEAK shows potential as alternative therapeutic strategy for psoriasis

Dec. 2, 2021

New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D

Nov. 30, 2021

Oncostatin M targeting as approach for treating inflammatory pruritus

Nov. 30, 2021

IL-17A/IL-17RA interaction modulators patented by Janssen Pharmaceutica

Nov. 25, 2021

Chinese researchers synthesize new phosphodiesterase PDE4 inhibitors

Nov. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...